Key facts
- Cobionix’s last known valuation is $14.0M (Jun 2023).
- It has raised $5.3M.
- Notable investors include Creative Destruction Lab, Endless Frontier Labs, Matter (Consulting Services (B2B)), MassRobotics, Innovation Factory (Hamilton) — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Cobionix
- ·The full record, as it builds
Funding rounds
No funding rounds for Cobionix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cobionix
Developer of an autonomous robotics platform intended to perform procedural tasks. The company's platform bridges skilled labor gaps within healthcare, manufacturing, logistics, and other industries and offers robot deployment with ongoing, customized support to scale, a multi-sensing, intelligent robot capable of performing procedural tasks with full autonomy, enabling vaccine clinics to reach populations in remote areas with limited access to medical care.
- Sector
- Information Technology
- HQ
- Kitchener, Canada
- Founded
- 2021
- Employees
- 13
- Website
- cobionix.com/
- Ownership
- Privately Held (backing)
Cobionix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cobionix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cobionix in its N-PORT filings yet. We sweep new filings monthly.